会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Synthesis of methotrexate-containing heterodimeric molecules
    • 含甲氨蝶呤的异二聚体分子的合成
    • US07230101B1
    • 2007-06-12
    • US10651340
    • 2003-08-28
    • Krishna K. MurthiChase C. Smith
    • Krishna K. MurthiChase C. Smith
    • C07D475/00A01N43/58
    • C07D475/08
    • The present invention relates to novel compositions of methotrexate-containing heterodimeric probe molecules, also known as chemical inducers of dimerization (CID), useful in three-hybrid assays. The invention further relates to synthesis of said compositions and their intermediates. Another aspect of the invention is a method for using the heterodimeric probe molecules described herein in drug screens to identify potential protein targets to a given ligand, optimize protein-ligand interactions, or identify potential ligands for a given protein target. In certain embodiments, the invention contemplates the synthesis of the following methotrexate-containing heterodimeric probe:
    • 本发明涉及含有甲氨蝶呤的异二聚体探针分子的新型组合物,也称为二聚化学化学诱导剂(CID),可用于三杂交测定。 本发明还涉及所述组合物及其中间体的合成。 本发明的另一方面是使用本文所述的异二聚体探针分子在药物筛选中鉴定给定配体的潜在蛋白质靶标,优化蛋白质 - 配体相互作用或鉴定给定蛋白质靶标的潜在配体的方法。 在某些实施方案中,本发明涵盖了以下含有甲氨喋呤的异二聚体探针的合成: